Article
Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease.
Current research in translational medicine - 1 Jun 2024
Heitzer Andrew M, Rashkin Sara R, Trpchevska Ana, Longoria Jennifer N, Rampersaud Evadnie, Olufadi Yunusa, Wang Winfred C, Raches Darcy, Potter Brian, Steinberg Martin H, King Allison A, Kang Guolian, Takemoto Clifford M, Hankins Jane S
Abstract excerpt
PURPOSE: Neurocognitive impairment is a common and debilitating complication of sickle cell disease (SCD) resulting from a combination of biological and environmental factors. The catechol-O-methyltransferase (COMT) gene modulates levels of dopamine availability in the prefrontal cortex. COMT has repeatedly been implicated in the perception of pain stimuli and frequency of pain crises in patients with SCD and is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
